J&J to pay $1B for implant maker Mentor

Johnson & Johnson has agreed to acquire breast-implant maker Mentor for $1.07 billion. The deal could also give Allergan a big rival in the wrinkle-fighting space, as Mentor awaits FDA approval for a Botox competitor. Release | Report

Suggested Articles

artists conception 2019
Manufacturing

Real estate group creating gene therapy CDMO at former GSK site

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

by Eric Palmer
amgen
Pharma Asia

Amgen amps up in Asia with full control of Astellas Japanese JV

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.

by Angus Liu
bms
Pharma

CAR-T damages at $1.5B? BMS demands more from Gilead patent win

After a jury ordered Gilead's Kite Pharma to pay $752 million for CAR-T patent infringement, BMS is asking for punitive damages in that amount, too.

by Eric Sagonowsky